Viscofan, S.A.

BME:VIS Voorraadrapport

Marktkapitalisatie: €2.9b

Viscofan Balans Gezondheid

Financiële gezondheid criteriumcontroles 5/6

Viscofan heeft een totaal eigen vermogen van €932.5M en een totale schuld van €243.1M, wat de schuld-eigenvermogensverhouding op 26.1% brengt. De totale activa en totale passiva bedragen respectievelijk €1.4B en €475.5M. De EBIT Viscofan is €197.5M waardoor de rentedekking 48.4 is. Het heeft contanten en kortetermijnbeleggingen van €64.7M.

Belangrijke informatie

26.1%

Verhouding schuld/eigen vermogen

€243.11m

Schuld

Rente dekkingsratio48.4x
Contant€64.67m
Aandelen€932.49m
Totaal verplichtingen€475.55m
Totaal activa€1.41b

Recente financiële gezondheidsupdates

Is Viscofan (BME:VIS) Using Too Much Debt?

Dec 21
Is Viscofan (BME:VIS) Using Too Much Debt?

Viscofan (BME:VIS) Has A Pretty Healthy Balance Sheet

Sep 20
Viscofan (BME:VIS) Has A Pretty Healthy Balance Sheet

Here's Why Viscofan (BME:VIS) Can Manage Its Debt Responsibly

May 25
Here's Why Viscofan (BME:VIS) Can Manage Its Debt Responsibly

Is Viscofan (BME:VIS) Using Too Much Debt?

Jan 07
Is Viscofan (BME:VIS) Using Too Much Debt?

Viscofan (BME:VIS) Has A Pretty Healthy Balance Sheet

Sep 01
Viscofan (BME:VIS) Has A Pretty Healthy Balance Sheet

Does Viscofan (BME:VIS) Have A Healthy Balance Sheet?

Mar 25
Does Viscofan (BME:VIS) Have A Healthy Balance Sheet?

Recent updates

Analyst Estimates: Here's What Brokers Think Of Viscofan, S.A. (BME:VIS) After Its Third-Quarter Report

Oct 26
Analyst Estimates: Here's What Brokers Think Of Viscofan, S.A. (BME:VIS) After Its Third-Quarter Report

Estimating The Fair Value Of Viscofan, S.A. (BME:VIS)

Oct 08
Estimating The Fair Value Of Viscofan, S.A. (BME:VIS)

Viscofan, S.A.'s (BME:VIS) Popularity With Investors Is Under Threat From Overpricing

Sep 25
Viscofan, S.A.'s (BME:VIS) Popularity With Investors Is Under Threat From Overpricing

Here's Why We Think Viscofan (BME:VIS) Might Deserve Your Attention Today

Aug 17
Here's Why We Think Viscofan (BME:VIS) Might Deserve Your Attention Today

Viscofan, S.A. (BME:VIS) Interim Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Aug 02
Viscofan, S.A. (BME:VIS) Interim Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Viscofan (BME:VIS) Shareholders Will Want The ROCE Trajectory To Continue

Jun 26
Viscofan (BME:VIS) Shareholders Will Want The ROCE Trajectory To Continue

Viscofan, S.A. (BME:VIS) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

Apr 20
Viscofan, S.A. (BME:VIS) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

Why We Think Viscofan, S.A.'s (BME:VIS) CEO Compensation Is Not Excessive At All

Apr 11
Why We Think Viscofan, S.A.'s (BME:VIS) CEO Compensation Is Not Excessive At All

Is There An Opportunity With Viscofan, S.A.'s (BME:VIS) 38% Undervaluation?

Apr 04
Is There An Opportunity With Viscofan, S.A.'s (BME:VIS) 38% Undervaluation?

Some Shareholders Feeling Restless Over Viscofan, S.A.'s (BME:VIS) P/E Ratio

Mar 18
Some Shareholders Feeling Restless Over Viscofan, S.A.'s (BME:VIS) P/E Ratio

Slowing Rates Of Return At Viscofan (BME:VIS) Leave Little Room For Excitement

Jan 17
Slowing Rates Of Return At Viscofan (BME:VIS) Leave Little Room For Excitement

Is Viscofan (BME:VIS) Using Too Much Debt?

Dec 21
Is Viscofan (BME:VIS) Using Too Much Debt?

Is There An Opportunity With Viscofan, S.A.'s (BME:VIS) 37% Undervaluation?

Nov 15
Is There An Opportunity With Viscofan, S.A.'s (BME:VIS) 37% Undervaluation?

Viscofan (BME:VIS) Has A Pretty Healthy Balance Sheet

Sep 20
Viscofan (BME:VIS) Has A Pretty Healthy Balance Sheet

Returns On Capital At Viscofan (BME:VIS) Have Stalled

Aug 29
Returns On Capital At Viscofan (BME:VIS) Have Stalled

Is There An Opportunity With Viscofan, S.A.'s (BME:VIS) 32% Undervaluation?

Aug 11
Is There An Opportunity With Viscofan, S.A.'s (BME:VIS) 32% Undervaluation?

Here's Why Viscofan (BME:VIS) Can Manage Its Debt Responsibly

May 25
Here's Why Viscofan (BME:VIS) Can Manage Its Debt Responsibly

Viscofan's (BME:VIS) Dividend Will Be Increased To €0.4374

May 04
Viscofan's (BME:VIS) Dividend Will Be Increased To €0.4374

Here's Why We Think Viscofan (BME:VIS) Is Well Worth Watching

Apr 24
Here's Why We Think Viscofan (BME:VIS) Is Well Worth Watching

The Returns At Viscofan (BME:VIS) Aren't Growing

Mar 02
The Returns At Viscofan (BME:VIS) Aren't Growing

Estimating The Intrinsic Value Of Viscofan, S.A. (BME:VIS)

Feb 16
Estimating The Intrinsic Value Of Viscofan, S.A. (BME:VIS)

Is Viscofan (BME:VIS) Using Too Much Debt?

Jan 07
Is Viscofan (BME:VIS) Using Too Much Debt?

Returns On Capital At Viscofan (BME:VIS) Have Stalled

Nov 29
Returns On Capital At Viscofan (BME:VIS) Have Stalled

Viscofan, S.A.'s (BME:VIS) Intrinsic Value Is Potentially 77% Above Its Share Price

Nov 11
Viscofan, S.A.'s (BME:VIS) Intrinsic Value Is Potentially 77% Above Its Share Price

Viscofan (BME:VIS) Has A Pretty Healthy Balance Sheet

Sep 01
Viscofan (BME:VIS) Has A Pretty Healthy Balance Sheet

Viscofan (BME:VIS) Has Some Way To Go To Become A Multi-Bagger

Aug 03
Viscofan (BME:VIS) Has Some Way To Go To Become A Multi-Bagger

Viscofan's (BME:VIS) Returns Have Hit A Wall

May 03
Viscofan's (BME:VIS) Returns Have Hit A Wall

Does Viscofan (BME:VIS) Have A Healthy Balance Sheet?

Mar 25
Does Viscofan (BME:VIS) Have A Healthy Balance Sheet?

Is Viscofan, S.A. (BME:VIS) Trading At A 38% Discount?

Mar 06
Is Viscofan, S.A. (BME:VIS) Trading At A 38% Discount?

Here's Why We Think Viscofan (BME:VIS) Is Well Worth Watching

Jan 15
Here's Why We Think Viscofan (BME:VIS) Is Well Worth Watching

Returns At Viscofan (BME:VIS) Appear To Be Weighed Down

Dec 29
Returns At Viscofan (BME:VIS) Appear To Be Weighed Down

Viscofan (BME:VIS) Has A Rock Solid Balance Sheet

Nov 24
Viscofan (BME:VIS) Has A Rock Solid Balance Sheet

Is Viscofan, S.A. (BME:VIS) Trading At A 24% Discount?

Oct 10
Is Viscofan, S.A. (BME:VIS) Trading At A 24% Discount?

With EPS Growth And More, Viscofan (BME:VIS) Is Interesting

Sep 23
With EPS Growth And More, Viscofan (BME:VIS) Is Interesting

Returns On Capital At Viscofan (BME:VIS) Have Stalled

Aug 19
Returns On Capital At Viscofan (BME:VIS) Have Stalled

Viscofan (BME:VIS) Has A Rock Solid Balance Sheet

Aug 03
Viscofan (BME:VIS) Has A Rock Solid Balance Sheet

A Look At The Fair Value Of Viscofan, S.A. (BME:VIS)

May 17
A Look At The Fair Value Of Viscofan, S.A. (BME:VIS)

Viscofan (BME:VIS) Could Easily Take On More Debt

Apr 07
Viscofan (BME:VIS) Could Easily Take On More Debt

Should We Be Excited About The Trends Of Returns At Viscofan (BME:VIS)?

Mar 04
Should We Be Excited About The Trends Of Returns At Viscofan (BME:VIS)?

Here's What Viscofan, S.A.'s (BME:VIS) Shareholder Ownership Structure Looks Like

Feb 17
Here's What Viscofan, S.A.'s (BME:VIS) Shareholder Ownership Structure Looks Like

Viscofan, S.A.'s (BME:VIS) Stock Has Shown A Decent Performance: Have Financials A Role To Play?

Feb 02
Viscofan, S.A.'s (BME:VIS) Stock Has Shown A Decent Performance: Have Financials A Role To Play?

A Look At The Intrinsic Value Of Viscofan, S.A. (BME:VIS)

Jan 18
A Look At The Intrinsic Value Of Viscofan, S.A. (BME:VIS)

Why Viscofan's (BME:VIS) CEO Pay Matters

Dec 26
Why Viscofan's (BME:VIS) CEO Pay Matters

Income Investors Should Know That Viscofan, S.A. (BME:VIS) Goes Ex-Dividend Soon

Dec 13
Income Investors Should Know That Viscofan, S.A. (BME:VIS) Goes Ex-Dividend Soon

Should Viscofan, S.A. (BME:VIS) Be Part Of Your Dividend Portfolio?

Dec 04
Should Viscofan, S.A. (BME:VIS) Be Part Of Your Dividend Portfolio?

The Returns At Viscofan (BME:VIS) Provide Us With Signs Of What's To Come

Nov 19
The Returns At Viscofan (BME:VIS) Provide Us With Signs Of What's To Come

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( €793.1M ) VIS } overtreffen de korte termijn passiva ( €336.8M ).

Langlopende schulden: De kortetermijnactiva VIS ( €793.1M ) overtreffen de langetermijnschulden ( €138.7M ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 19.1% ) VIS wordt als voldoende beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van VIS is de afgelopen 5 jaar gestegen van 20.7% naar 26.1%.

Schuldendekking: De schuld van VIS wordt goed gedekt door de operationele kasstroom ( 87.5% ).

Rentedekking: De rentebetalingen op de schuld van VIS worden goed gedekt door EBIT ( 48.4 x dekking).

Balans

Ontdek gezonde bedrijven

7D

1Y

7D

1Y

7D

1Y